ALXA PDUFA date for Adasuve set for December 21 2012

Jul 05, 2012 No Comments by

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that FDA accepted its resubmitted ADASUVE New Drug Application (NDA) and assigned a new PDUFA date of December 21, 2012. The company has previously received complete response letters (CRLs) in both October 2010 and a second in May 2012.

 

Daily News

About the author

Currently residing in New Zealand and employed in the education industry, Mr. A. Burden holds a M.Com in International Business from the University of Sydney and used these skills together with his passion for investing to establish BioPharmCatalyst in June 2010 as a tool for investing decisions in the US pharmaceutical market. He spends much of his free time mountain biking, playing squash and hiking.
No Responses to “ALXA PDUFA date for Adasuve set for December 21 2012”

Leave a Reply